MACAN WILLIAM ANDREW 4
4 · Neuronetics, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Neuronetics (STIM) EVP William Macan Sells 14,120 Shares
What Happened William Andrew Macan, EVP, Chief Legal Officer and CS of Neuronetics (STIM), sold 14,120 shares in an open-market transaction on February 12, 2026. The reported weighted-average price was $1.65 per share, for total proceeds of $23,298. The sale was a disposition (code S) and was done to satisfy tax withholding obligations tied to the vesting of restricted stock units.
Key Details
- Transaction date: 2026-02-12
- Shares sold: 14,120; weighted-average price: $1.65; price range reported: $1.56–$1.72 (sold in multiple transactions)
- Total reported proceeds: $23,298
- Footnote F1: Sale was non‑discretionary to cover tax withholding on RSU vesting
- Footnote F2: Price is a weighted average; seller can provide per‑trade breakdown on request
- Shares owned after transaction: not specified in the supplied filing summary
- Filing timing: Report filed 2026-02-18 (six days after the transaction date), which is later than the typical two-business-day Form 4 filing window
Context This was a routine tax-withholding sale tied to vested restricted stock units, not a discretionary market-timing sale; such transactions are common and do not by themselves indicate a change in the insider's view of the company. The sale occurred in multiple trades across a small price range; the filer offers to provide the exact per-trade prices on request.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-02-12$1.65/sh−14,120$23,298→ 673,561 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.56 to $1.72. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.